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Regulation of renal tubular secretion of organic compounds. has recently been extended by the identification, using
Background. Information on the molecular basis underlying molecular cloning techniques, of specific transport pro-
organic anion and cation transport in renal tubules has ex- teins, which mediate the translocation of organic anionspanded in recent years with the identification and characteriza-
and cations across cell membranes to result in net vecto-tion of numerous transporters. However, little is known about
rial secretion into the tubular lumen. Regulation of thesethe regulation of this transport.
Methods. Both English and Russian language studies deal- processes has great practical significance, since suppres-
ing with the regulation of organic ion transport by the kidney sion of tubular secretion may increase the exposure of
have been reviewed. the body to potentially dangerous synthetic and natural
Results. This review summarizes the literature on the physio-
xenobiotics, while on the other hand, stimulation of tubu-logical and pharmacological aspects of the regulation of organic
lar transport may be useful for prevention or treatmention transport, linking this information where possible to under-
lying transport mechanisms. Current models of the tubular secre- of occupational diseases by elimination of environmental
tion of organic anions and cations are reviewed. Factors that toxins. The present review therefore briefly summarizes
inhibit or enhance tubular secretion of xenobiotics are described, the literature on the physiological and pharmacological
and their influence on proximal tubule cell transport and func-
aspects of the regulation of tubular secretion, and re-tion is discussed. Important roles for substrate stimulation, the
views recent information on the transport proteins thatadrenergic nervous system, numerous hormones, P-glycopro-
tein, and protein kinase C activity have been identified. carry out this tubular transport.
Conclusions. Despite considerable advances in the under-
standing of basic transport pathways and mechanisms involved
in the tubular secretion of organic compounds, there is still PHYSIOLOGICAL ASPECTS OF THE
relatively little information on the regulation of this transport. REGULATION OF RENAL ORGANIC
Studies combining the techniques of integrative and cell physi- ANION AND CATION TRANSPORTology and molecular biology will provide significant new in-
sights into the pathways regulating the tubular transport of Cellular transporters and their regulation
these compounds. Specific transport proteins transfer organic compounds
into tubular fluid. The best studied is the multidrug trans-
porter P-glycoprotein. P-glycoproteins are proteins iso-
The renal tubular transport of organic substances plays lated from cell membranes, and they possess ATPase
an essential role in the removal of xenobiotics, such as activity. They belong to a superfamily of transport pro-
drugs, numerous chemicals contained in our environ- teins that contain an adenosine 59-triphosphate (ATP)
ment, and some metabolites out of the body. The mecha- binding cassette. Other family members include the mul-
nisms mediating tubular secretion have been intensively tidrug resistance (MDR)-associated proteins Mrp1 and
studied over the past several decades, and the features Mrp2 and the multispecific organic anion transporter
of organic anion and cation transport, the nature of carri- (MOAT). They are often called MDR proteins because
ers and their interaction with substrates, and the forces they hasten removal of cytotoxic drugs from the cell
driving transport through basolateral and luminal mem- interior and thus are associated with resistance of tumor
branes have been characterized [1–5]. This information cells to the action of these drugs [reviewed in 6–10].
The physiological role of P-glycoproteins may be in the
protection of the organism from xenobiotics [8, 9]. InKey words: anion and cation transport, cellular transporters, neural
proximal tubule epithelium, P-glycoprotein is normallycontrol, cardiac glycosides, diuretics, protein synthesis, antineoplastic
agents, immunomodulators. expressed on the apical membrane of cells [11], where
it can mediate transport into the tubular fluid (Fig. 1).Received for publication October 6, 1999
Numerous drugs are secreted into the tubular lumenand in revised form July 6, 2000
Accepted for publication July 17, 2000 through the P-glycoprotein pathway independent of or
in addition to the organic anion and cation secretoryÓ 2001 by the International Society of Nephrology
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Fig. 1. Schematic diagram of the pathways
involved in organic anion transport by proxi-
mal tubule cells, and the major sights of regu-
lation of transport. Transport proteins are in-
dicated by open circles with arrows showing
the direction of transport. Individual compo-
nents of transport are indicated by the letters.
The electrogenic basolateral Na1,K1-ATPase
(A) maintains the out . in Na1 gradient and
the cell interior negative with respect to the
outside. Na1 moves into the cell down this
electrochemical gradient with a-ketoglutarate
(aKG5) (B). aKG5 then exchanges with or-
ganic anions via the organic anion transporter
(OAT); (C); para-aminohippurate (PAH2) is
used, for example. aKG5 then cycles back into
the cell via pathway (B). PAH2 traverses the
cell to the apical lumen, or enters into cyto-
plasmic vesicles (data not shown). Secretion
of PAH2 into the tubular lumen occurs by
facilitated diffusion down its electrochemical
gradient (D) or by anion exchange (E). Some
organic compounds undergo secretion into the
lumen via multidrug resistance-associated pro-
tein 2 (Mrp2) located in the apical membrane
(F) in a process utilizing ATP. Mechanisms
of regulation of transport are shown by the
numbers in circles. Increased activity of pro-
tein kinase C (PKC) resulting from actions of
hormones and transmitters (1) leads to inhibi-
tion of OAT- and Mrp2-mediated transport.
Nuclear acting mechanisms include steroid
hormones and substrate stimulation, which al-
ter transcription to increase the amount of
transporter protein synthesis (2). Inhibitors of
Na1,K1-ATPase (3) alter organic anion trans-
port indirectly by reducing the Na1 gradient.
Finally, many compounds inhibit Mrp2 activ-
ity (4), discussed in the text. Modified with
permission from Pritchard JB: Renal han-
dling of organic acids and bases, in Textbook
of Nephrology (4th ed), edited by Massry SG,
Glassock RJ, Baltimore, Lippincott Williams
and Wilkins (in press).
pathways described later in this article. These include used for immunosuppression in organ transplant pa-
tients. CsA acts by binding to P-glycoprotein [17] anddigoxin [12], quinolone antibacterial drugs [13], rapa-
mycin [14], and colchicine and other agents [9]. In the inhibits the tubular transport of vinblastine and vincris-
tine [18] as well as digoxin [19].case of rapamycin, transport can be inhibited by cyclo-
sporine A (CsA) and other substrates for P-glycoprotein, Mrp2 is also located in high concentration in the brush
border of proximal tubular cells [20] and shares manybut not by para-aminohippurate (PAH) or tetraethylam-
monium (TEA) [14], compounds that are secreted by properties with P-glycoprotein. However, substrate spec-
ificities differ, with P-glycoprotein transporting primarilythe organic anion and cation pathways (described later
in this article). In the case of quinolone compounds, uncharged and cationic species, while Mrp2 transports
conjugated anionic compounds [21, 22]. In addition,interactions with these anion and cation transport steps
have also been demonstrated in addition to P-glycopro- there is only approximately 25% amino acid homology
between Mrp2 and P-glycoproteins [21, 23].tein transport [15]. The mechanism by which P-glycopro-
tein mediates drug secretion is not entirely clear, but Organic anions are transported into the tubular cell
across the basolateral membrane in a process energizedexisting data support a drug pump model [9]. Many
drugs, called chemosensitizers, antagonize MDR and indirectly by the sodium gradient. In a current model,
sodium enters the cell with a-ketoglutarate, driven bythereby improve the effect of chemotherapeutic antitu-
mor agents. Among them are calcium channel blockers, the sodium gradient (Fig. 1). This is followed by a-keto-
glutarate/organic anion exchange, transferring the or-steroids (such as progesterone), and immunosuppres-
sants, most notably CsA [16], which is the principal drug ganic anion into the cell. Ongoing cellular metabolic
Berkhin and Humphreys: Regulation of tubular secretion 19
Table 1. Some characteristics of cloned organic anion and cation transporters
Amino Membrane
Transporter Source acids localization Main substrates References
Anion transporters
rOAT1, rROAT1 Rat kidney 551 Basolateral PAH [29, 30, 35, 59]
NKT (mOAT1) Mouse kidney 546 PAH [31]
fROAT1 Winter flounder kidney 562 Basolateral PAH [32]
hOAT1 (hPAHT) Human kidney 563, 550 Basolateral PAH, nucleoside phosphonates [28, 33, 34, 36]
hOAT3 Human kidney 568 Basolateral PAH [34]
oatp Rat liver, kidney Basolateral, Bromosulfothalein [37]
apical
OAT-K1 Rat kidney, renal cell line 669 Apical, Methotrexate [38, 39]
basolateral
OAT-K2 Rat kidney 498 Apical Methotrexate, taurocholate [40]
Cation transporters
rOCT1 Rat kidney, liver, intestine 556 Basolateral TEA, methyl-phenylpyridinium [41]
rOCT1A Rat kidney, intestine 430 TEA [41, 43]
rOCT2 Rat kidney 593 TEA [45]
rbOCT1 Rabbit liver, kidney, intestine 554 Methylphenyl-pyridinium [55]
hOCT1 Human liver, renal cell line 554 Apical TEA [44, 46]
hOCT2 Human liver 555 Apical TEA, methyl-phenylpyridinium [46]
hOCTN1 Human fetal liver 551 Apical TEA [48]
hOCTN2 Human placenta, kidney 557 Apical TEA, methylphenylpyridinium [49, 50]
activity supports this exchange by maintaining the intra- OAT1 mRNA [28], but urate had no effect on PAH
uptake by oocytes expressing rat OAT1 in another studycellular concentration of dicarboxylate (a-ketoglutarate)
to facilitate anion exchange. Thus, cellular entry is uphill [29]. The basis for these divergent results has not been
established. Differences in some features of the proteinagainst an electrochemical gradient, in turn maintained
by the Na1,K1-ATPase [2, 24], and inhibition of this such as its size [28, 34] suggest that other forms of OAT1
may exist. A human OAT3 has been identified by homol-enzyme inhibits organic anion accumulation [25–27].
Within the cell, organic anions can be bound or seques- ogy cloning and also maps to chromosome 11 [34]. It has
43% homology to human OAT1, but its substrates havetered within vesicles and are extruded across the luminal
membrane into tubular fluid by anion exchange or facili- not yet been characterized. Also identified in rat kidney
are two other transporters, OAT-K1 and OAT-K2, withtated diffusion [2, 24]. A family of organic anion trans-
porters (OATs) from human, rat, mouse, and flounder somewhat different molecular features and transport
properties than OAT1; they appear localized to apical[28–32] has recently been identified (Table 1). These
transporters are expressed in various tissues, including rather than basolateral membranes of cells in the S3
segment of the proximal tubule and have been classifiedkidney, liver, and brain, but major interest has focused
on OAT1, which is strongly expressed in kidney but only as members of the oatp family [37–40].
These advances in the understanding of organic anionweakly or not at all in other tissues [28, 30, 33]. Human
OAT1 maps to chromosome 11 and encodes a 563 amino transport have been paralleled by the cloning of a group
of organic cation transporters (OCTs), which mediateacid protein with 12 predicted membrane-spanning re-
gions [28, 34]. In the kidney, it is localized to the basolat- transport of a variety of organic cations (Table 1) [41, 42].
These bear some homology to OATs with respect toeral surface of proximal tubule cells [28, 35]. When ex-
pressed in Xenopus oocytes or transfected cells, OAT1 size, amino acid composition, and membrane topology
[29, 31, 42]. Four OCTs have been cloned to date. OCT1exhibits the functional properties identified in earlier
studies of proximal tubular function: concentrative uptake has been identified in rat, rabbit, and human and is ex-
pressed chiefly in liver, with lower levels of expressionof the organic anion PAH, which is enhanced by trans
dicarboxylic acids such as a-ketoglutarate and glutarate, in kidney and intestine. An alternatively spliced variant,
OCT1A, has been identified in kidney, liver, and intes-and inhibited by a variety of cis-acting agents, including
probenecid, furosemide, indomethacin, and a-ketogluta- tine [43]. Human OCT1 is polyspecific, with uptake of
the organic cation TEA being inhibited by a variety ofrate [28–30, 32–34]. This transporter also has affinity
for the nucleoside phosphonates cidofovir and adefovir, compounds, including clonidine, quinine, and verapamil
[44]. Differences between hOCT1 and rOCT1 occur inantiviral agents that are nephrotoxic [36]. It is not clear
whether urate is a substrate for OAT1: 14C-urate uptake both tissue distribution and substrate characteristics
[41, 42]. OCT2 is expressed primarily in kidney and brain,occurred in oocytes expressing rat OAT1 [30]. Urate
inhibited PAH uptake by oocytes injected with human but renal expression predominates. Within the kidney,
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Fig. 2. Schematic diagram of organic cation
transport by renal tubular epithelial cells and
its regulation. Symbols are the same as
described in Figure 1. The electrochemical
gradient for Na1 is maintained by the Na1,-
K1-ATPase (A). Organic cations (Org cat)
enter the cell by facilitated diffusion down the
electrical gradient (B) or by simple diffusion
and are then taken up into cytoplasmic vesi-
cles (data not shown) or diffuse to the apical
membrane. Transfer into tubular fluid occurs
via P-glycoprotein electrogenic secretion for
larger molecules (C) or by hydrogen-cation
exchange (D), which is, in turn, linked to the
Na1-H1 antiporter (E), for smaller molecules
such as tetraethylammonium (TEA1). As with
organic anion transport, regulation occurs via
PKC inhibition of P-glycoprotein and OCTs
(1), and alterations in nuclear transcription
(2). Inhibition of Na1,K1-ATPase activity (3)
inhibits organic cation entry into the cell by
reducing the transmembrane potential differ-
ence and reduces secretion across the apical
membrane by reducing Na1-H1 exchange
(discussed in the text). Modified with permis-
sion from Pritchard JB: Renal handling of
organic acids and bases, in Textbook of Ne-
phrology (4th ed), edited by Massry SG,
Glassock RJ, Baltimore, Lippincott Williams
and Wilkins (in press).
transcripts are more abundant in medulla than cortex driving force for cellular uptake. To the extent that these
treatments depolarize the cell, potential-dependent up-[45]; immunocytochemical studies place the protein on
the apical border of the distal tubule [46]. The concept take will also be reduced. Considerable evidence indi-
cates that protein kinase C (PKC) can be an importantof multiple OCTs is further supported by the character-
ization of an organic cation efflux pathway in opossum regulator of organic ion transport. Both OATs and OCTs
possess several PKC phosphorylation sites [28–30, 39,kidney cells, which is sensitive to some nucleosides [47].
Transport of organic cations is thought to proceed via 41–43, 55], and experimental studies indicate that activa-
tion of PKC, by cAMP or with phorbol esters, inhibitsthese transporters down an electrical gradient into the
cell across the basolateral membrane and is therefore uptake of compounds like PAH and TEA [33, 56–59].
Transepithelial transport of the organic anion fluoresceinpotential-dependent. Compartmentalization within the
cell can occur as is true for organic anions, and a variety by perfused rabbit tubules is also inhibited by phorbol
ester; this inhibition was blocked by the PKC inhibitorsof extrusion steps across the brush border into the tubu-
lar fluid and uptake back into the cell has been described staurosporine and bisindolylmaleimide [60]. Some stud-
ies link this effect of PKC activation to inhibition of entry(Fig. 2) [24, 41, 42]. Some of these may include the other
two cloned cation transporters, OCTN1 and OCTN2 into the cell across the basolateral membrane [56–58, 61],
whereas another study has suggested that it could be[48–50]. These transporters are located on the apical
membrane and exhibit pH-dependent transport consis- mediated by PKC inhibition of Na1,K1-ATPase in the
tubular cell, since transport was also inhibited by dopa-tent with a proton-cation antiporter [51]. In addition,
OCTN2 also displays sodium-dependent carnitine trans- mine and stimulated by oxymetazoline [62]. Against this
view of PKC activation inhibiting cellular uptake ofport [52, 53]; this is unique among transporters to have
two separate mechanisms of organic compound translo- organic ions are studies indicating that phorbol esters
actually stimulate uptake of TEA and PAH across thecation in the same molecule. Human OCTN1 and OCTN2
share 77% amino acid homology [49], but homology with basolateral membrane of rabbit proximal tubular cells
[63, 64]. The PKC inhibitor staurosporine lowered trans-OCT1 and OCT2 is 31 to 37% [48, 49].
Little is known about cellular events regulating or- port of organic compounds and prevented the stimula-
tion of transport caused by phorbol esters [64]. At pres-ganic anion and cation transport in the proximal tubule.
Inhibition of sodium transport by agents such as ouabain ent, there is no obvious way to reconcile these divergent
observations. It may be that the effects of PKC on tubular[54] or vanadate [25–27], which inhibit the Na1,K1-
ATPase, disrupt the out . in sodium gradient and the secretion reflect different actions of the enzyme on
Berkhin and Humphreys: Regulation of tubular secretion 21
Na1,K1-ATPase or on the transporters depending on vent the compensatory increase in tubular secretion fol-
lowing unilateral nephrectomy [70], indicating that theoxygen availability and presumably the metabolic state
of the tissue [62]. The bulk of evidence indicates that mechanism of this increase is not neurally mediated but
is perhaps due to humoral or hemodynamic factors. Elec-PKC activation inhibits the transepithelial transport of
organic compounds via an effect on basolateral trans- trical stimulation of renal efferent nerves leads to an
increase in the maximal transport of diodrast [71]. Stud-porters to reduce cellular uptake (Figs. 1 and 2). Since
PKC is activated by numerous neural and humoral path- ies of the effects of increases (efferent nerve stimulation)
or decreases (denervation) in renal nerve activity onways, it seems likely that it represents a major intracellu-
lar regulatory mechanism for organic ion transport. It tubular transport are in some ways at odds with pharma-
cologic studies. Among adrenergic agents, no direct ef-should also be noted that P-glycoprotein and Mrp2 also
possess numerous phosphorylation sites [9, 10]. PKC reg- fect on tubular secretion was observed in dogs or rats
after intravenous infusion of norepinephrine, isoprotere-ulation of P-glycoprotein–mediated secretion of xenobi-
otics has been demonstrated recently in a manner sug- nol [72], or dopamine [73]. Diodrast transport changed
only when the glomerular filtration rate changed simulta-gesting an inverse relationship between PKC activity and
P-glycoprotein-mediated transport [65], much as has also neously. This lack of effect could be related to the com-
plex hemodynamic changes that occur during intrave-been suggested for organic anion transport (Fig. 1) [58].
Additionally, a recent study indicates that endothelins nous infusion of these agents. In contrast are the results
obtained using membrane vesicles from renal tubularinhibit ATP-mediated organic compound secretion via
P-glycoprotein and Mrp2 in killifish proximal tubules cells. Epinephrine and norepinephrine enhanced PAH
transport into basolateral membrane vesicles prepared[22]. This action of endothelins was mediated by the ETB
receptor and likely involved activation of PKC, since from rat proximal tubules [74]. The effect was mediated
by adrenoreceptors. Clonidine, an a2-adrenergic agonist,inhibitors of the enzyme blocked the decrease in tubular
secretion [22]. This study underscores the importance of also produced an elevation of uptake into these vesicles
[74]. These results were confirmed in a study of dichloro-neural and humoral agents that regulate tubular trans-
port of organic compounds via effects on PKC activity. phenoxyacetic acid transport in primary cultures of win-
ter flounder proximal tubule cells. The a-adrenergic ago-Some data indicate an interaction of nonsteroidal anti-
inflammatory drugs (NSAIDs) with anion transport. nist oxymetazoline stimulated, and dopamine inhibited,
secretion of this organic anion [62]. Acetylcholine didAlthough indomethacin cis inhibits PAH transport by
OAT1, most likely through competition for transport not change the maximum secretion of PAH [75] or dio-
drast [76] after infusion into the renal artery in dogs,[28, 30, 33], one study observed that NSAIDs inhibited
methotrexate transport by OAT-K1 but were not trans- despite the renal vasodilation that likely occurred. This
suggests that renal nerve effects are also not solely dueported themselves [66]. This opens the possibility that
inhibition of prostaglandin synthesis by NSAIDs may to hemodynamic changes. This conclusion is further sup-
ported by studies in isolated segments of rabbit proximalinhibit some OATs. An effect of albumin to stimulate
transcellular transport of organic compounds has been tubule in which the a-adrenergic agonist phenylephrine
inhibited organic anion transport via a PKC-mediatedhypothesized, although the mechanism by which this ef-
fect occurs has not been defined [67, 68]. mechanism [60, 61].
Older studies demonstrate the importance of endo-In summary, the mechanisms involved in the regula-
tion of tubular secretion of xenobiotics at the cellular level crine glands, particularly anterior pituitary, thyroid, and
gonads, in the regulation of tubular secretion. Hypophy-include the activity of Na1,K1-ATPase, which indirectly
influences cellular uptake by maintaining the sodium gra- sectomy decreases the tubular transport of PAH in vivo
and in vitro [77, 78]. This effect may reflect deficiencydient and transmembrane potential, PKC activity, which
inhibits the transporters, expression of P-glycoprotein, of growth hormone because administration of growth
hormone increased tubular transport in both hypophy-Mrp2, OAT1, and other transporters, the protein binding
of substrates, and other factors (Figs. 1 and 2). Further sectomized and intact animals [77]. Tubular transport of
organic substances is also reduced after thyroidectomystudy of the regulation of transporter function will no
doubt reveal new mechanisms that could be important and is restored by thyroxine therapy [77]. The effect
of thyroid hormones on tubular secretion may be age-in understanding the body’s defense against xenobiotics.
related. Hirsch and Hook found that administration of
Neural and hormonal control triiodothyronine (T3) to weanling rats for three or seven
days caused an increase in PAH transport in renal corti-A role of renal efferent nerves in the regulation of
tubular secretion has been identified in studies utilizing cal slices while treatment of adult rats did not alter trans-
port significantly [79]. When added to renal slices in vitro,renal denervation or electrical stimulation of the renal
nerves. Renal excretion of PAH in the dog is decreased T3 inhibited PAH uptake. This confirmed the earlier
observation concerning thyroxine action in vitro [80] andafter renal denervation [69]. Denervation does not pre-
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was considered to be the result of competition with PAH, gonadectomized male rats can be prevented by aurantin
[93] and is therefore likely due to enhanced synthesis ofsince the hormone is transported as an organic anion [79].
Subsequent studies demonstrated that thyroid hormones RNA and proteins. Related to these observations are
others demonstrating sex-related differences in tubularincreased tubular secretion in adult rats and rabbits with-
out a change in glomerular filtration rate (GFR). Auran- transport. Renal cortical slices from male rats accumu-
late PAH to a greater extent than those from femaletin, which blocks the synthesis of mRNA and protein,
prevented the stimulation of secretion by thyroid hor- rats [92, 94–96]. This is also true regarding the organic
cation TEA [96]. Castration of male rats causes a reduc-mones [81, 82], suggesting that an effect on gene tran-
scription likely occurs in addition to any competition for tion in tubular secretion, which is corrected by treatment
with testosterone, while bilateral ovariectomy does nottransport. Bra¨unlich confirmed the increase in tubular
secretion by thyroid hormones administered to rats of alter tubular secretion in female rats [92, 94, 95]. Testos-
terone treatment increases the number of functional car-different ages [83, 84]; the effect was associated with
an increase in protein synthesis in kidney tissue [85]. riers for PAH in the kidney [97]. However, some xenobi-
otics are transported better by female animals; amongRecently, stimulation of PAH secretion by T3 has also
been observed in frog kidneys [86]. These studies are these are perfluorooctanoic acid [98], pentachloronitro-
benzene [99], zenarestat [100], and nilvadipine [101].consistent with earlier organ ablation experiments dem-
onstrating that thyroidectomy reduced tubular transport Species differences also exist: The sex difference in the
excretion of zenarestat is seen in mice and rats, but notof organic substances [77].
Parathyroid hormone and its intracellular second mes- in dogs or humans [102]. It must be born in mind that the
clearance methods used in these studies have limitations,senger cAMP (1024 mol/L) both increase PAH uptake
by suspensions of rabbit renal cortical tubules. A higher and other factors, including transport by the liver, may
play a role in the excretion of these drugs. More directconcentration of cAMP (1023 mol/L) inhibits PAH up-
take, probably by a competitive mechanism [87]. The methods, such as determination of maximum transport
(Tm), or experiments in vitro, are necessary to clarifydata do not agree regarding the effect of increased intra-
cellular cAMP caused by isoproterenol or theophylline underlying mechanisms. Although the data on tubular
effects of estrogens are not clear at present, these obser-on PAH transport [88]. Parathyroid hormone-mediated
inhibition of PAH transport in opossum kidney epithelial vations in aggregate suggest important differences in tu-
bular secretion related to the sex steroids, with testoster-cells [56] was attributed to activation of PKC [56, 57];
the role of PKC on tubular secretion has been discussed one being a potent stimulator of transport and estrogen
having a lesser effect.previously in this article. Insulin effects on organic ion
transport have also been observed. Intravenous injection This summary leads to the conclusion that hormonal
influences on tubular secretion of organic compoundsin dogs increased the Tm of diodrast while urine flow and
excretion of sodium and potassium diminished without take place through at least two pathways (Figs. 1 and 2).
One involves regulation through a cytoplasmic action(s),change in GFR [89]. Similarly, infusion of insulin into a
renal artery was accompanied by a unilateral increase likely mediated by PKC and perhaps other mechanisms.
This pathway may be the one used by hormones andin tubular secretion and decrease in urinary sodium and
potassium excretion. In rabbits, insulin stimulated the transmitters interacting with receptors on the surface
of the tubular epithelial cell. The other occurs throughaccumulation of diodrast by renal cortical slices whether
the hormone was injected into the animals or added to effects on nuclear transcription and may involve synthe-
sis of new transporters and substrates important in tubu-the incubation medium of the slices [89]. The mechanism
of this effect of insulin on organic ion transport has not lar secretion. This pathway is likely the one by which
steroid hormones and perhaps other regulators act. Fu-been established.
Steroid hormones have also been shown to influence ture research will expand information on these regula-
tory pathways and no doubt uncover other ones by whichorganic ion transport. Single injections of hydrocortisone
(cortisol) increase diodrast excretion in dogs and rabbits regulation of tubular secretion occurs.
and cause an increase in uptake of this compound by
Substrate stimulationrabbit renal cortical slices. However, prolonged adminis-
tration of hydrocortisone has the opposite effect [90]. Hirsch and Hook were the first to demonstrate that
prior injection of penicillin (twice daily for 3 days) toPrednisolone and dexamethasone increase the excretion
of PAH and its accumulation by renal slices in immature rabbit pups two weeks old led to an increase in the
uptake of PAH by kidney cortical slices [103–105]. Thebut not in adult rats, while triamcinolone is effective
regardless of age [91]. The administration of testosterone effect was shown in only immature rabbits or rats and
was not present after four weeks of age when tubularincreases the accumulation of PAH by renal slices from
female but not male rats [92]. This stimulatory effect secretion reached the adult level. This increase in anion
uptake was not paralleled by an increase in the uptakeof testosterone on tubular secretion in female rats and
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of the organic cation N-methylnicotinamide. When preg- stimulation of tubular secretion, since the phenomenon
has been observed not only after repeated injections ofnant rabbits were treated with penicillin during the last
half of pregnancy, PAH transport was increased in renal substrates three times daily for three days, but also after
administration of the substrate only twice during oneslices from the newborns in the first days of life. Substrate
stimulation of organic anion transport in renal slices was day [116].
Varshavsky has reported unique data concerning theconfirmed later in newborn dogs [106]. This phenomenon
is considered to be a result of increased biosynthesis dynamics of tubular secretion during continuous intrave-
nous infusion of diodrast and inulin in rats and dogsof transport proteins, since pretreatment with penicillin
leads to greater incorporation of leucine and glutamine [117]. In these experiments, Tm of diodrast was estimated
every 5 to 10 minutes for 2 hours, during which timeinto the slice proteins and to enhancement of protein
content in the microsomal fraction, whereas administra- three levels of Tm were identified: the first from 5 to 25
minutes (the background), the second from 35 to 55tion of the protein synthesis inhibitor cycloheximide to
nursing rats prevents substrate stimulation of PAH up- minutes, and the third from 65 to 120 minutes. Tm in the
second period had increased to 136 to 139% of back-take by renal slices [107]. In addition to these studies
on renal cortical slices, substrate stimulation of tubular ground and in the third period to 178 to 181%, where
it remained stable. Thus, substrate stimulation of tubularsecretion has been demonstrated using separated renal
tubules from newborn rabbits [108] and also in in vivo secretion appears to be a gradually incremental process.
Finally, [14C]TEA transport by opossum kidney cells isexperiments in newborn dogs [109].
Several reports have described substrate stimulation enhanced after exposure to organic cations such as cho-
line or N-methylnicotinamide [abstract; Chan and Gia-of tubular secretion not only in newborn but also in adult
animals [110, 111]. Repeated administration of phenol comini, Pharm Res 10(Suppl):S411, 1993], suggesting that
substrate stimulation of cation transport may also occur.red, penicillin, cyclopenthiazide, and other substrates led
to an increase of renal excretion of PAH regardless of Morphological correlates of substrate stimulation have
been variably observed. No histologic changes in renalage [112]. Pretreatment with penicillin and diodrast stim-
ulates their tubular secretion by adult rat kidneys, while cortical slices from penicillin-induced PAH accumula-
tion in immature rabbits were noted [118], nor wereinhibitors of protein synthesis, puromycin, and cyclohex-
imide prevent this effect [113]. The ability of cyclohexi- ultrastructural changes seen in proximal tubules of two-
week-old rabbits receiving penicillin twice daily for 2mide to prevent substrate stimulation has been confirmed
using renal slices from adult rats [114]. In aggregate, the days and sacrificed 24 hours after the final injection [119].
However, another group detected some morphologicaldata from these [107, 113, 114] and other studies argue
that substrate stimulation occurs as a result of increased changes in rats after substrate stimulation with diodrast
injections administered three times a day [120, 121]. Re-synthesis of protein transporters involved in the secre-
tion of the organic compounds. The most convincing nal cortical slices made four hours after the final injection
showed increases in the number of ribosomes and in theresults concerning substrate stimulation of tubular secre-
tion in vivo have been obtained from determination of diameter of microcisterns in the endoplasmic reticulum
in proximal tubular cells, as well as an increase in thethe Tm of penicillin or diodrast in conscious dogs in con-
trol experiments and again after three days of admin- number and size of microbodies [120, 121]. The signifi-
cance of these ultrastructural changes is not known.istration of the substrates three times daily [115]. A
significant increase in maximum transport of both com-
pounds was observed, while glomerular filtration was
PHARMACOLOGICAL ASPECTS
unchanged.
Nervous system agentsThe reason that substrate stimulation of tubular secre-
tion has been demonstrated in only immature animals Older reports examined the effect of hypnotics on
tubular secretion. Despopoulos investigated the effectby some investigators but also in adults by others is not
known for certain, but may depend on the time after of barbiturates on the accumulation of PAH by rabbit
kidney cortex slices [122]. Most of them, including barbi-preliminary substrate administration that transport is
measured. If penicillin or diodrast is injected into adult tal, phenobarbital, and hexobarbital, decreased transport
without a reduction in oxygen utilization. They did notanimals three times daily for three days, substrate stimu-
lation can be shown up to 18 hours after the last injection alter the transport of the organic cation TEA, indicating
a specific effect on organic anion transport. On the other[113]. Since tubular secretion in newborn animals is very
low, the duration of substrate stimulation may be pro- hand, amobarbital and secobarbital decreased oxygen
consumption and the transport of both PAH and TEA,longed up to 24 hours after the last injection or even
later, whereas in adult animals the stimulation does not suggesting a more global effect on transport. Pentobarbi-
tal injected intravenously reduced the maximum trans-last as long. It should be pointed out that the number
of preliminary injections of substrate is not critical for port of PAH in dogs [123, 124] and decreased the uptake
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of PAH and oxygen consumption by rat kidney slices Diuretics
[125]. Hexobarbital, whether given by intravenous injec- The effect of mercurial diuretics on tubular secretion
tion to rabbits or by infusion into the left renal artery has been reviewed [133]. As to modern diuretics, single
to dogs, reduced the tubular secretion of diodrast; in the doses of hydrochlorothiazide and cyclopenthiazide did
latter case, tubular secretion in the right kidney remained not change tubular secretion in rats, whereas daily ad-
unchanged [126]. These studies indicate that barbiturates ministration of hydrochlorothiazide (20 mg/kg to rats
inhibit tubular secretion by a direct influence on tubule and 5 mg/kg to dogs for 10 days) and cyclopenthiazide
cells, either by altering metabolism or by a competitive (50 mg/kg to rats) led to a gradual increase in the tubular
interaction with the transporters. The administration of secretion of diodrast [134, 135]. The authors suggested
the central nervous stimulants strychnine or amphet- that these results reflected substrate stimulation of tubu-
lar transport. Furosemide reduced the secretion of peni-amine failed to change renal tubular secretion in rabbits
cillin in rats [136] and the accumulation of PAH by iso-and dogs [126].
lated S2 segments of rat proximal tubules [137]. TheIt has recently been shown that ethanol (10 to 40
results may be due to competition, since furosemide ismmol/L) stimulates uptake of the organic anion fluores-
secreted by the organic anion transport system. Breslercein in proximal tubules of rat renal slices, an effect that
and Natochin demonstrated that furosemide, ethacrynicwas abolished by inhibition of ethanol oxidation [127].
acid, triamterene, and other diuretics in doses inhibitingThis observation was interpreted to indicate that the
sodium reabsorption reduced the transport of fluoresceinincrease of tubular transport by ethanol is mediated by
through the luminal membrane of frog proximal tubulesthe production of acetate, well known as a stimulant of
[138]. Single subcutaneous injections of furosemide intubular secretion [1, 2].
therapeutic doses did not affect the tubular secretion of
diodrast in rats and dogs [139]. The explanation of di-Cardiac glycosides
uretic effects on tubular secretion is complex in view ofSeveral reports indicate that PAH accumulation by
the competitive interaction with other secreted sub-rat or rabbit renal cortical slices [54, 128, 129] or primary
stances on the one hand and the ability for substratecultures of winter flounder proximal tubule cells [130]
stimulation on the other. It seems likely that therapeuticis reduced if the medium contains cardiac glycosides. In
doses of modern diuretics do not change tubular secre-vivo, infusion of strophanthin (ouabain) into the renal
tion significantly.artery of dogs at 10 mg/min led to an initial small but
significant increase in maximum transport of diodrast in Protein synthesis stimulants and inhibitors
the infused kidney, followed by a decrease as sodium
Since testosterone stimulates tubular secretion by en-excretion increased [131]. At an infusion rate of 25 mg/min,
hancing protein synthesis, as discussed previously in this
tubular secretion decreased without the initial rise, the
article, it has been of interest to study the effect of syn-
maximum reduction of diodrast transport coinciding with
thetic anabolic steroids. The administration of nandro-
the time of maximum natriuresis. These results were later lone decanoate for seven days to dogs and rats caused
confirmed in vitro by studying the influence of ouabain a pronounced increase in renal diodrast secretion, which
on organic anion transport in rabbit renal slices [132]. was accompanied by a rise in protein content in the
At an ouabain concentration of 1025 to 1024 mol/L, inhi- microsomal fraction of renal cortical cell homogenates
bition of PAH transport took place, but lower concentra- [140]. Similar results were obtained using another ana-
tions (1027 to 1026 mol/L) stimulated PAH transport. bolic agent, potassium orotate. Daily administration of
This dual effect of ouabain was attributed to changes in this compound for 7 days to rats and 10 days to dogs led
intracellular sodium and potassium concentrations, since to a marked increase in tubular secretion of diodrast as
lower concentrations of ouabain (,1026 mol/L) did not well as to an increase in protein synthesis in the renal
change intracellular cation content [132]. The impor- cortex [141]. Two different inhibitors of protein synthe-
tance of Na1,K1-ATPase for tubular secretion is also sis, cycloheximide and aurantin, effectively blocked the
indicated by the effect of a potent inhibitor of this en- ability of potassium orotate to stimulate the tubular
zyme, vanadate, that markedly decreased PAH and TEA transport of xenobiotics [141]. Thus, agents that stimu-
accumulation by rat renal cortical slices [25, 26] and PAH late protein synthesis lead to an increase in the transport
secretion in isolated rabbit proximal tubules [27]. The of organic compounds, while inhibitors of protein synthe-
importance of the sodium gradient in energizing organic sis produce the opposite effect. It is to be presumed that
ion transport was discussed previously in this article. these effects are mediated by stimulation or inhibition
Inhibition of the Na1,K1-ATPase disrupts this gradient of the synthesis of transport proteins such as OAT1 and
and thereby inhibits tubular secretion indirectly rather OCT1 themselves.
Microsomal enzyme inducers have long been knownthan by a direct action on the transporters themselves.
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to stimulate hepatic drug metabolism, but little has been that will decrease organic ion transport indirectly by
disrupting the sodium gradient, as discussed earlier.reported about their effects on the renal transport of
xenobiotics despite the presence in the proximal tubule
Cytostatic (antineoplastic) agentsof the cytochrome P450-monooxygenase system. The ad-
Antineoplastic drugs and x-irradiation also have ef-ministration of the classical microsomal inducers, pheno-
fects on renal tubular transport of xenobiotics by inhib-barbital and 3-methylcholanthrene increased PAH up-
iting synthesis of nucleic acids and proteins in tubulartake by renal cortical slices from immature rabbits [142].
transport systems. Administration of 6-mercaptopurineAlso, the administration of phenobarbital (50 mg/kg, 4
for 10 days to rabbits and dogs causes a dose-dependentdays) and 3-methylcholanthrene (20 mg/kg, 2 days) to
depression of tubular secretion of diodrast; uptake of dio-rats was accompanied by a large increase in excretion
drast by rabbit renal cortical slices is also decreased [148].and maximum transport of diodrast without change in
A single intravenous injection of cyclophosphamide inurine flow or increase in glomerular filtration rate [143].
rabbits (60 to 80 mg/kg) and dogs (40 mg/kg) leads to aAnother inducer of the monooxygenase system, zixorin,
marked inhibition of diodrast excretion, an effect accom-stimulated the tubular secretion of diodrast when admin-
panied by reduced accumulation of the xenobiotic byistered to rats (100 mg/kg, 4 days), and this effect lasted
renal slices [149]. It is of interest that addition of cyclo-for a few days after the end of the treatment [144].
phosphamide directly to the slice incubation mediumThe mechanism of the increase in tubular secretion by
had no effect on active transport, but if the compoundmicrosomal enzyme inducers is not clear yet. It could be
was injected into rabbits, the accumulation of diodrastsecondary to stimulation of biotransformation processes
was reduced considerably [149]. This conforms to theor to enhancement of tubular transport system activity.
view that cyclophosphamide must be activated in the bodyInjection of aurantin, an inhibitor of protein synthesis
in order to liberate an effective alkylating derivative.related to actinomycin D (0.1 mg/kg subcutaneously
The wide application of cisplatin as an antineoplasticdaily for 3 or 4 days) to rats, led to a small increase in
agent is limited by its nephrotoxicity. In experimentsdiodrast secretion on the second day and to a more
in rats, cisplatin impairs the ability of renal slices toconsiderable decrease of secretion in the four to eight
accumulate both PAH and TEA for some days afterdays after starting the injections [145]. Renal cortical
the injection [150, 151]; the addition of cisplatin to theslices of treated rats accumulated diodrast less efficiently
incubation medium reduced the accumulation of these(S/M 5 3.8 6 0.34 compared with 5.7 6 0.35 in control).
organic compounds in a dose-dependent manner [152,When aurantin was added to the slice medium at a con-
153]. Sulfofluorescein accumulation by cortical tissue iscentration of 0.01 mg/mL, the S/M ratio increased a small
also reduced [150]. The nephrotoxicity of cisplatin is
amount; when the concentration was higher (0.02 mg/mL),
probably linked to its tubular secretion by both anion
the S/M ratio decreased. Intravenous injection of auran- and cation transport systems and to its ability to depress
tin (0.125 mg/kg) in dogs decreased the maximum trans- renal metabolism, including Na1,K1-ATPase activity
port of diodrast significantly. The changes in tubular [154]. Thus, its effects to decrease transport of organic
secretion in rats correlated with the protein content in compounds are probably both direct and indirect.
renal cortical tissue. RNA content was reduced simulta- Whole-body irradiation causes depression of tubular
neously with the decrease in secretion [145], suggesting secretion, but it is not clear whether the effect is due to
a global effect of the drug on gene transcription and a direct action on renal tissue. Local single-dose
subsequent protein synthesis. x-irradiation of dog kidneys with 2400 R did not cause
Some antibiotics that inhibit protein synthesis also re- a marked change in PAH transport [155]. However,
duce tubular transport of organic compounds. Tetracy- Brukhanov observed a reduction of tubular secretion
cline, oxytetracycline, and chlortetracycline, when ad- not only with whole-body irradiation of rabbits but also
ministered to dogs (150 mg/kg daily for 10 days), inhibit after local x-irradiation of the kidney area with a dose
tubular secretion; chloramphenicol causes the same ef- of 86 R/minutes over 30 minutes (total dose 2580 R)
fect by single and repeated administration in rats [133]. [156]. Glomerular filtration rate and urine flow did not
The aminoglycoside antibiotics neomycin and mono- change significantly.
mycin decrease tubular secretion, whereas kanamycin in
Immunomodulatorslow doses improves tubular transport [133]. Aminogly-
coside nephrotoxicity is associated not only with inhibi- As has been described previously in this article, some
tion of ribosomal protein synthesis, but also in part with drugs with immunosuppressive activity, including cyto-
an alteration in the expression of genes critical for proxi- static agents and high doses of hydrocortisone decrease
mal tubule metabolism and maintenance of basolateral tubular secretion. CsA is a widely used potent immuno-
transport [146]. In rats treated with gentamicin, Na1,K1- suppressive drug that selectively inhibits T lymphocytes.
The influence of CsA on tubular secretion is difficult toATPase activity in tubule cells is reduced [147], an effect
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study since it markedly reduces renal blood flow. It has the addition of an antioxidant inhibits the peroxidation
and restores the accumulation of PAH [163].been shown, using a kidney epithelial cell line and the
isolated perfused rat kidney, that CsA inhibits the tubu-
lar secretion of digoxin [19], while on the other hand,
CONCLUSION
digoxin does not affect CsA transport. The authors inter-
A few years ago, Pritchard and Miller noted the impor-preted this effect of CsA as due to modification of the
tance of studying the regulation of tubular secretion [24].multidrug transporter P-glycoprotein in tubular cells, as
This review has attempted to summarize currently avail-discussed earlier. It is also possible that inhibition of the
able information on this subject. The regulation of tubu-tubular secretory system by CsA may be related to its
lar transport is best viewed using an integrated approachability to suppress renal microsomal protein synthesis
[164], taking into account the interaction between renal[157] or to inhibition of PKC [158]. This latter is specula-
and hepatic excretion [165–168] as well as the role oftive since, as discussed previously in this article, the bulk
renal cell organelles in the compartmentalization andof evidence indicates that PKC activation rather than
transcellular transport of organic substances [2, 121, 169].inhibition inhibits transport of organic compounds.
Xenobiotics are generally recognized as an importantOnly a few reports have studied the effects of immuno-
cause of human diseases, including chemical allergies,stimulants on tubular transport. The bacterial lipopoly-
diverse immunodeficiencies, and malignant tumors. It issaccharide prodigiosan (0.05 mg/kg) and the synthetic
now accepted that preservation of overall homeostasiscompound levamisole (10 mg/kg) injected subcutane-
occurs through the operation of different mechanisms.ously to rats three times every other day caused an in-
One of these is the immune system, which deals withcrease in tubular secretion and excretion of diodrast; the
macromolecular xenobiotics, mainly foreign proteins. An-increase in diodrast excretion by prodigiosan was 21%
other involves the liver, which excretes some xenobioticsand by levamisole 28%. Transport returned to baseline
into bile and hydroxylates or conjugates others. The thirdone week after the end of treatment [159]. Since levami-
is the system of secretion by the renal proximal tubules.sole is an immunomodulator and its effect depends on
Tubular secretion, which evolved during the early stepsthe dose, a larger dose of the drug (50 mg/kg) with no
of phylogenesis, allows for excretion of foreign low mo-immunostimulant action was tested. Under these circum-
lecular weight compounds or excess amounts of endoge-stances, tubular secretion remained unchanged [159].
nous substances, providing protection for the organismThus levamisole activates the tubular transport of xeno-
from potential toxicities. These pathways for defensebiotics only in an immunostimulating dose (10 mg/kg).
against foreign substances may be interrelated: proteinAnother immunostimulant, 5-oxymethyluracil (50 mg/kg
synthesis inhibitors such as cycloheximide, aurantin, anddaily for 7 days), also increased tubular secretion in rats.
tetracyclines, and immunosuppressants like CsA, x-irra-The maximum transport of diodrast was 36% higher than
diation, large doses of cortisol, 6-mercaptopurine, cyclo-basal, while glomerular filtration did not change [160].
phosphamide, and cisplatin all suppress tubular transportA number of compounds with immunologic activity have
of xenobiotics as well as inhibit the immune response,been obtained from the thymus. One of these is Tactivin
while immune stimulants like prodigiosan, tactivin and(or T-activin). Administered to rats, Tactivin increased
levamisol, and agents, which stimulate protein synthesismaximum tubular transport of diodrast on average by
like anabolic steroids and thyroid hormones, enhance73% without change in glomerular filtration, an effect
tubular secretion. In many cases, it is not yet possible tothat returned to control levels six days after the end of
determine whether regulation of transport of organicTactivin injections [161]. The mechanism of stimulation
compounds occurs via a direct effect on the transportersof tubular transport by these immunostimulants is not
themselves or through indirect actions such as alterationsknown, but it is attractive to speculate that it could occur
in cell metabolism or changes in the sodium gradient.through an increase in tubular cell protein synthesis.
Future research is necessary to clarify this important
Miscellaneous issue. Substrate stimulation of tubular secretion has the
obvious benefit of accelerating removal of a potentiallyThere are several old reports about the reduction of
toxic compound to which the body may be exposed re-tubular secretion in dogs and rats caused by salicylates
petitively. Given the increasing number of xenobioticsas well as after prolonged administration of aminopyrine,
introduced into our environment, tubular secretion is aphenylbutazone, and acetaminophen, whereas vitamin
critical body function, and further study of its regulationA has been shown to stimulate the tubular transport of
and its interaction with other protective systems shouldxenobiotics [reviewed in 133]. Folic acid has also been
reveal novel ways by which protection could be en-shown to stimulate renal PAH transport [162]. Among
hanced. The identification of the molecular pathwaysmore recent reports, attention has been paid to agents
and transporters involved in tubular secretion will facili-that induce lipid peroxidation; they decrease PAH accu-
mulation by rat renal cortical slices significantly, while tate this effort.
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